KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Outstanding
Ratios

CRISPR Therapeutics AG (CRSP) Shares Issued (2016 - 2025)

Historic Shares Issued for CRISPR Therapeutics AG (CRSP) over the last 10 years, with Q3 2025 value amounting to $278.1 million.

  • CRISPR Therapeutics AG's Shares Issued rose 453276.69% to $278.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $301.6 million, marking a year-over-year increase of 231.6%. This contributed to the annual value of $300.7 million for FY2024, which is 81896.64% up from last year.
  • According to the latest figures from Q3 2025, CRISPR Therapeutics AG's Shares Issued is $278.1 million, which was up 453276.69% from -$22000.0 recorded in Q2 2025.
  • CRISPR Therapeutics AG's Shares Issued's 5-year high stood at $280.7 million during Q1 2024, with a 5-year trough of -$1.3 million in Q2 2021.
  • For the 5-year period, CRISPR Therapeutics AG's Shares Issued averaged around $51.2 million, with its median value being $9.0 million (2023).
  • Per our database at Business Quant, CRISPR Therapeutics AG's Shares Issued surged by 1885689.05% in 2021 and then plummeted by 10603.64% in 2024.
  • CRISPR Therapeutics AG's Shares Issued (Quarter) stood at -$1.3 million in 2021, then soared by 287.02% to $2.5 million in 2022, then soared by 263.03% to $9.0 million in 2023, then skyrocketed by 66.29% to $15.0 million in 2024, then surged by 1759.11% to $278.1 million in 2025.
  • Its last three reported values are $278.1 million in Q3 2025, -$22000.0 for Q2 2025, and $8.5 million during Q1 2025.